(Q51550699)

English

Troglitazone reduces plasma levels of tumour necrosis factor-alpha in obese patients with type 2 diabetes.

scientific article published in June 2000

Statements

Troglitazone reduces plasma levels of tumour necrosis factor-alpha in obese patients with type 2 diabetes. (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit